Brief Summary
Postoperative pulmonary complications (PPCs) are a major cause of morbidity and mortality in surgical patients. National estimates suggest 1,062,000 PPCs per year, with 46,200 deaths, and 4.8 million additional days of hospitalization. The objective of the study is to develop and implement perioperative strategies to eliminate PPCs in abdominal surgery, the field with the largest absolute number of PPCs. We will conduct a randomized controlled pragmatic trial in 750 studied participants. The effectiveness of an individualized perioperative anesthesia-centered bundle will be compared to the usual anesthetic care in patients receiving open abdominal surgery. At the end of this project, the investigators expect to change clinical practice by establishing a new and clinically feasible anesthesia-centered strategy to reduce perioperative lung morbidity. The research will be conducted across 14 US academic centers, and will be funded by the National Institute of Health.
Brief Title
An Anesthesia-Centered Bundle to Reduce Postoperative Pulmonary Complications: The PRIME-AIR Study
Detailed Description
Postoperative pulmonary complications (PPCs) are a major cause of morbidity and mortality in surgical patients. National estimates suggest 1,062,000 PPCs per year, with 46,200 deaths, and 4.8 million additional days of hospitalization. Abdominal surgery is the field with the largest absolute number of PPCs. The long-term goal is to develop and implement perioperative strategies to eliminate PPCs. Whereas PPCs are as significant and lethal as cardiac complications, research in the field has received much less attention, and strategies to minimize PPCs are regrettably limited. Recently, the investigators and others have suggested a crucial role of anesthesia related interventions such as ventilatory strategies, and administration and reversal of neuromuscular blocking agents in reducing PPCs. These findings are consistent with the beneficial effects of lung protective ventilation during the adult respiratory distress syndrome (ARDS). While surgical patients differ substantially from ARDS patients as most have no or limited lung injury at the start of surgery, intraoperative anesthetic and abdominal surgery interventions result in lung derecruitment and predispose to or produce direct and indirect, potentially multiple-hit, lung injury. Thus, effective anesthetic strategies aiming at early lung protection in this group of patients are greatly needed. Indeed, the current lack of evidence results in wide and unexplained variability in anesthetic practices creating a major public health issue as some practices within usual care appear to be suboptimal and even potentially injurious. The investigators hypothesize that an anesthesia-centered bundle, based on recent findings and focused on perioperative lung protection, will minimize multiple and synergistic factors responsible for the multiple-hit perioperative pulmonary dysfunction and result in decreased incidence and severity of PPCs. Founded on strong preliminary data, we will leverage a network of US academic centers to study this hypothesis in two aims: Aim 1. To compare the number and severity of PPCs in participants receiving an individualized perioperative anesthesia-centered bundle to those in participants receiving usual anesthetic care during open abdominal surgery. For this, the investigators propose to conduct a prospective multicenter randomized controlled pragmatic trial with a blinded assessor in a total of 750 studied participants. The bundle will consist of optimal mechanical ventilation comprising individualized positive end-expiratory pressure to maximize respiratory system compliance and minimize driving pressures, individualized use of neuromuscular blocking agents and their reversal, and postoperative lung expansion and early mobilization; Aim 2. To assess the effect of the proposed bundle on plasma levels of lung injury biomarkers. The investigators theorize that our intervention will minimize overinflation and atelectasis reducing plasma levels of biomarkers of lung inflammatory, epithelial, and endothelial injury. Such mechanistic insights will facilitate bundle dissemination and support adoption as it has for lung protective ventilation for ARDS. At the end of this project, the investigators expect to change clinical practice by establishing a new and clinically feasible anesthesia-centered strategy to reduce perioperative lung morbidity.
Categories
Completion Date
Completion Date Type
Actual
Conditions
Postoperative Pulmonary Complications
Eligibility Criteria
Inclusion Criteria:
* Adults (\>=18 years) scheduled for elective surgery with expected duration \>=2 hours
* Open abdominal surgery including: gastric, biliary, pancreatic, hepatic, major bowel, ovarian, renal tract, bladder, prostatic, radical hysterectomy, and pelvic exenteration
* Intermediate or high risk of PPCs defined by an ARISCAT (Assess Respiratory Risk in Surgical Patients in Catalonia Score) risk score\>=26
Exclusion Criteria:
* Inability or refusal to provide consent
* Inability or significant difficulty to perform any study interventions, including incentive spirometry, ambulation and/or maintaining follow-up contact with study personnel for up to 90 days after the date of surgery.
* Participation in any interventional research study within 30 days of the time of the study.
* Previous surgery within 30 days prior to this study.
* Pregnancy
* Emergency surgery
* Severe obesity (above Class I, BMI\>=35 kg/m2)
* Significant lung disease: any diagnosed or treated respiratory condition that (a) requires home oxygen therapy or non-invasive ventilation (except nocturnal treatment of sleep apnea without supplemental oxygen), (b) severely limits exercise tolerance to \<4 metabolic equivalents (METs) (e.g., patients unable to do light housework, walk flat at 4 miles/h or climb one flight of stairs), (c) required previous lung surgery, or (d) includes presence of severe pulmonary emphysema or bullae
* Significant heart disease: cardiac conditions that limit exercise tolerance to \<4 METs
* Renal failure: peritoneal or hemodialysis requirement or preoperative creatinine \>=2 mg/dL
* Neuromuscular disease that impairs ability to ventilate without assistance
* Severe chronic liver disease (Child-Turcotte-Pugh Score \>9, Appendix I)
* Sepsis
* Malignancy or other irreversible condition for which 6-month mortality is estimated \>=20%
* Bone marrow transplant
* Adults (\>=18 years) scheduled for elective surgery with expected duration \>=2 hours
* Open abdominal surgery including: gastric, biliary, pancreatic, hepatic, major bowel, ovarian, renal tract, bladder, prostatic, radical hysterectomy, and pelvic exenteration
* Intermediate or high risk of PPCs defined by an ARISCAT (Assess Respiratory Risk in Surgical Patients in Catalonia Score) risk score\>=26
Exclusion Criteria:
* Inability or refusal to provide consent
* Inability or significant difficulty to perform any study interventions, including incentive spirometry, ambulation and/or maintaining follow-up contact with study personnel for up to 90 days after the date of surgery.
* Participation in any interventional research study within 30 days of the time of the study.
* Previous surgery within 30 days prior to this study.
* Pregnancy
* Emergency surgery
* Severe obesity (above Class I, BMI\>=35 kg/m2)
* Significant lung disease: any diagnosed or treated respiratory condition that (a) requires home oxygen therapy or non-invasive ventilation (except nocturnal treatment of sleep apnea without supplemental oxygen), (b) severely limits exercise tolerance to \<4 metabolic equivalents (METs) (e.g., patients unable to do light housework, walk flat at 4 miles/h or climb one flight of stairs), (c) required previous lung surgery, or (d) includes presence of severe pulmonary emphysema or bullae
* Significant heart disease: cardiac conditions that limit exercise tolerance to \<4 METs
* Renal failure: peritoneal or hemodialysis requirement or preoperative creatinine \>=2 mg/dL
* Neuromuscular disease that impairs ability to ventilate without assistance
* Severe chronic liver disease (Child-Turcotte-Pugh Score \>9, Appendix I)
* Sepsis
* Malignancy or other irreversible condition for which 6-month mortality is estimated \>=20%
* Bone marrow transplant
Inclusion Criteria
Inclusion Criteria:
* Adults (\>=18 years) scheduled for elective surgery with expected duration \>=2 hours
* Open abdominal surgery including: gastric, biliary, pancreatic, hepatic, major bowel, ovarian, renal tract, bladder, prostatic, radical hysterectomy, and pelvic exenteration
* Intermediate or high risk of PPCs defined by an ARISCAT (Assess Respiratory Risk in Surgical Patients in Catalonia Score) risk score\>=26
* Adults (\>=18 years) scheduled for elective surgery with expected duration \>=2 hours
* Open abdominal surgery including: gastric, biliary, pancreatic, hepatic, major bowel, ovarian, renal tract, bladder, prostatic, radical hysterectomy, and pelvic exenteration
* Intermediate or high risk of PPCs defined by an ARISCAT (Assess Respiratory Risk in Surgical Patients in Catalonia Score) risk score\>=26
Gender
All
Gender Based
false
Healthy Volunteers
No
Last Update Post Date
Last Update Post Date Type
Actual
Last Update Submit Date
Minimum Age
18 Years
NCT Id
NCT04108130
Org Class
Other
Org Full Name
Columbia University
Org Study Id
AAAT9106
Overall Status
Completed
Phases
Not Applicable
Primary Completion Date
Primary Completion Date Type
Actual
Official Title
An Anesthesia-Centered Bundle to Reduce Postoperative Pulmonary Complications: The PRIME-AIR Study
Primary Outcomes
Outcome Description
The distribution of the number and severity of accumulated post-operative pulmonary complications (PPCs) between the control and intervention groups during the first 7 days after surgery.
Outcome Measure
Number and Severity of Postoperative Pulmonary Complications Between Participant Groups
Outcome Time Frame
Postoperative Days 0 through 7
Secondary Ids
Secondary Id
HL140177
Secondary Id
5UH3HL140177-03
Secondary Outcomes
Outcome Description
Individual grade 3 and 4 postoperative pulmonary complications within 7 days after the day of the surgery.
Outcome Time Frame
Postoperative Days 0 through 7
Outcome Measure
Number of Participants With Grade 1 and 2 Postoperative Pulmonary Complications
Outcome Description
Individual grade 3 and 4 postoperative pulmonary complications within 7, 30, and 90 days after the day of the surgery.
Outcome Time Frame
Postoperative Days 7, 30, and 90
Outcome Measure
Number of Participants With Grade 3 and 4 Postoperative Pulmonary Complications
Outcome Description
Presence of any hypoxemia (as defined in PPC grade 1 and 2) within 7 days after the day of the surgery.
Outcome Time Frame
Postoperative Days 0 through 7
Outcome Measure
Number of Participants With Hypoxemia by Postoperative Day 7
Outcome Description
Presence of atelectasis (radiological confirmation + either temperature \>37.5°C or abnormal lung symptoms/signs) by day 7 after the date of surgery.
Outcome Time Frame
Days 0 through 7 after the day of surgery
Outcome Measure
Number of Participants With Atelectasis by Postoperative Day 7
Outcome Description
Incidence of suspected (radiological evidence without bacteriological confirmation) and proved (radiological evidence and documentation of pathological organism) pneumonia by day 7 after the date of surgery.
Outcome Time Frame
Days 0 through 7
Outcome Measure
Number of Participants With Pneumonia (Suspected and Proved) by Postoperative Day 7
Outcome Description
Number of participants with ventilatory dependence (Grade 3, non-invasive or invasive ventilation \< 48h) or failure (Grade 4, postoperative non-invasive or invasive ventilation dependence ≥ 48h) by day 7 after the date of surgery.
Outcome Time Frame
Days 0 through 7
Outcome Measure
Number of Participants With Ventilatory Dependence or Failure by Postoperative Day 7
Outcome Description
Number of time (hours or days) spent in the postoperative oxygen therapy or other respiratory support
Outcome Time Frame
Up to 7 days post-surgery
Outcome Measure
Length of Postoperative Oxygen Support
Outcome Description
The incidence of both intraoperative hypoxemia (SpO2 \< 85%) and rescue recruitment maneuvers during surgery. Received unplanned RM or PEEP titrations or adjustments during surgery for oxygenation or ventilation rescue.
Outcome Time Frame
Day 0
Outcome Measure
Number of Participants With Both Intraoperative Hypoxemia and Rescue Recruitment Maneuvers
Outcome Description
Number of participants with hypotension, bradycardia, tachycardia, arrhythmias, new ST-segment changes and cardiac arrest
Outcome Time Frame
Day 0
Outcome Measure
Number of Participants With Intraoperative Cardiovascular Events
Outcome Description
Number of days the participant has spent in the hospital since the day of the surgery.
Outcome Time Frame
Days 0 through 7, 30, and 90
Outcome Measure
Length of Hospital Stay
Outcome Description
The number of participants with hospital readmission(s), other than to the Intensive Care Unit, if admitted.
Outcome Time Frame
After the date of discharge to day 90
Outcome Measure
Number of Participants With Other Hospital Readmission(s) After Initial Discharge
Outcome Description
Number of participants with arrhythmia, paralytic ileus, surgical site infection, infection (source uncertain), acute renal failure, and systemic inflammatory response syndrome.
Outcome Time Frame
Days 0 to 7
Outcome Measure
Number of Participants With Any Major Extrapulmonary Complications
Start Date
Start Date Type
Actual
Status Verified Date
First Post Date
First Post Date Type
Actual
First Submit Date
First Submit QC Date
Std Ages
Adult
Older Adult
Locked Fields
Render the field
Maximum Age Number (converted to Years and rounded down)
999
Minimum Age Number (converted to Years and rounded down)
18
Investigators
Investigator Type
Principal Investigator
Investigator Name
Matthias Eikermann
Investigator Email
meikermann@montefiore.org